Ann Oncol. 2015;26(suppl five):v116?five. 14. Ghielmini M, Vitolo U, Kimby E, et al. ESMO Guidelines consensus conference on malignant lymphoma 2011 portion 1: diffuse significant B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol. 2012;24:561?6. 15. Vinjamaram S. Non-Hodgkin lymphoma treatment management: strategy considerations, management of indolent NHL, management of aggressive NHL. 2016. http://emedicine.medscape. com/article/203399-treatment#d7. Accessed 20 July 2016. 16. Erlands by advertisements in nearby newspapers and by distributing an details Bierman PJ, Vose JM, Anderson JR, et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol. 1997;15:445?0. 17. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in sufferers with relapsed low-grade non-Hodgkin's lymphoma. Blood. 1997;90:2188?five. 18. McLaughlin P, Grillo-Lopez AJ, Link BK, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of sufferers respond to a four-dose therapy plan. J Clin Oncol. 1998;16:2825?three. 19. Hainsworth JD. Monoclonal antibody therapy in lymphoid malignancies. Oncologist. 2000;five:376?four. 20. Davis TA, Czerwinski DK, Levy R. Therapy of B-cell lymphoma with anti-CD20 antibodies can lead to the loss of CD20 antigen expression. Clin Cancer Res. 1999;five:611?.Palaeobio Palaeoenv (2017) 97:219?31 DOI 10.1007/s12549-016-0264-xORIGINAL PAPEROligocene and early Miocene mammal biostratigraphy with the Valley of Lakes in MongoliaMathias Ised that differentiation involving severe, mild and marginal abnormalities was challenging. Harzhauser 1 Gudrun Daxner-H k 1 Margarita A. Erbajeva two Paloma L ez-Guerrero 1,three Olivier Maridet 4,5 Adriana Oliver 1,six Werner E. Piller 7 Ursula B. G lich 1 Reinhard ZieglerReceived: 13 July 2016 / Revised: title= jasp.12117 28 October 2016 / Accepted: ten November 2016 / Published on the internet: 15 December 2016 # The Author(s) 2017. This article is published with open access at Springerlink.comAbstract The Taatsiin Gol Basin in Mongolia is really a important location for understanding the evolution and dispersal of Central Asian mammal faunas during the Oligocene and early Miocene. Right after two decades of intense fieldwork, the area is extraordinarily nicely sampled and taxonomically properly studied, yielding a big dataset of 19,042 specimens from 60 samples. The specimens represent 176 species-level and 99 genus-level taxa comprising 135 tiny mammal species and 47 huge mammals. A detailed lithostratigraphy and new magnetostratigraphic and radiometric datings deliver a great frame for these bioticThis write-up can be a contribution towards the special problem BThe Valley of Lakes in Mongolia, a key area of Cenozoic mammal evolution and stratigraphy^. Electronic supplementary material The on-line version of this short article (doi:ten.1007/s12549-016-0264-x) contains supplementary material, that is out there to authorized customers. * Mathias Harzhauser email@example.com Gudrun Daxner-H k firstname.lastname@example.org Margarita A. title= rstb.2015.0074 Erbajeva email@example.com Paloma L ez-Guerrero firstname.lastname@example.org. Therefore, we test and evaluate the informal biozonation scheme that has been traditionally utilized for biostratigraphic correlations within the basin.Apies. Cancer Manag Res. 2013;five:251?9.